The expression trends of DOCK1 and SLC25A1 were increased in AML, while the opposite was true for SLC14A1 and UCP2 in the GSE9476 and GSE13159 datasets (Supplementary Figure S1). This evidence concerns the gene DOCK1 and acute myeloid leukemia.